ARNA Financial Facts

Total interest and other expense, net: -1.49M
Net loss per share allocable to common stockholders, basic: -0.1
See Full Income Statement

Total current liabilities: -42.88M
Deferred revenues, less current portion: 101.33M
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 5/5/14 *Est. EPS Growth Rate -10.0% *Last Qtr.
Average EPS % Beat Rate +8.8% Revenue Growth Rate +219.6% *Last Qtr.
Average % Move 1-Wk after EPS +6.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/27/14 Q413 -$0.11-$0.11 $0.00$6.2M$7M N/A 0% Details
11/7/13 Q313 -$0.08-$0.12 +$0.04$3.6M$5.3M N/A +51.5% Details
8/1/13 Q213 $0.18$0.15 +$0.03$68.9M$57.3M N/A -10.6% Details
5/2/13 Q113 $0.09$0.11 -$0.02N/A$50.36M N/A -26.1% Details
3/4/13 Q412 -$0.10-$0.03 -$0.07$1.94M$21.94M N/A -25.5% Details
11/6/12 Q312 -$0.07-$0.09 +$0.02$1.49M$3.51M N/A -18% Details
8/9/12 Q212 -$0.12-$0.08 -$0.04$22M$7.38M N/A -16.2% Details
3/14/12 Q411 -$0.16-$0.15 -$0.01$2.08M$3.49M N/A +246.9% Details